Adherex Technologies (FENC) Competitors $8.67 -0.26 (-2.91%) Closing price 04:00 PM EasternExtended Trading$8.67 0.00 (0.00%) As of 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock FENC vs. CRON, CRMD, UPB, SYRE, QURE, URGN, RAPP, ABUS, PHAT, and TSHAShould you be buying Adherex Technologies stock or one of its competitors? The main competitors of Adherex Technologies include Cronos Group (CRON), CorMedix (CRMD), Upstream Bio (UPB), Spyre Therapeutics (SYRE), uniQure (QURE), Urogen Pharma (URGN), Rapport Therapeutics (RAPP), Arbutus Biopharma (ABUS), Phathom Pharmaceuticals (PHAT), and Taysha Gene Therapies (TSHA). These companies are all part of the "pharmaceutical products" industry. Adherex Technologies vs. Its Competitors Cronos Group CorMedix Upstream Bio Spyre Therapeutics uniQure Urogen Pharma Rapport Therapeutics Arbutus Biopharma Phathom Pharmaceuticals Taysha Gene Therapies Adherex Technologies (NASDAQ:FENC) and Cronos Group (NASDAQ:CRON) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, valuation, earnings, profitability, media sentiment and analyst recommendations. Do analysts prefer FENC or CRON? Adherex Technologies presently has a consensus target price of $13.33, indicating a potential upside of 53.79%. Given Adherex Technologies' stronger consensus rating and higher possible upside, analysts plainly believe Adherex Technologies is more favorable than Cronos Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Adherex Technologies 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.00Cronos Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do insiders and institutionals believe in FENC or CRON? 55.5% of Adherex Technologies shares are owned by institutional investors. Comparatively, 8.7% of Cronos Group shares are owned by institutional investors. 11.8% of Adherex Technologies shares are owned by insiders. Comparatively, 7.3% of Cronos Group shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Which has more risk and volatility, FENC or CRON? Adherex Technologies has a beta of 0.58, indicating that its share price is 42% less volatile than the S&P 500. Comparatively, Cronos Group has a beta of 1.13, indicating that its share price is 13% more volatile than the S&P 500. Is FENC or CRON more profitable? Cronos Group has a net margin of 14.19% compared to Adherex Technologies' net margin of -35.05%. Adherex Technologies' return on equity of 0.00% beat Cronos Group's return on equity.Company Net Margins Return on Equity Return on Assets Adherex Technologies-35.05% N/A -23.92% Cronos Group 14.19%-3.78%-3.62% Does the media refer more to FENC or CRON? In the previous week, Adherex Technologies had 2 more articles in the media than Cronos Group. MarketBeat recorded 2 mentions for Adherex Technologies and 0 mentions for Cronos Group. Adherex Technologies' average media sentiment score of 0.67 beat Cronos Group's score of 0.50 indicating that Adherex Technologies is being referred to more favorably in the media. Company Overall Sentiment Adherex Technologies Positive Cronos Group Positive Which has stronger earnings and valuation, FENC or CRON? Cronos Group has higher revenue and earnings than Adherex Technologies. Adherex Technologies is trading at a lower price-to-earnings ratio than Cronos Group, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAdherex Technologies$47.54M5.09-$440K-$0.42-20.64Cronos Group$130.28M7.70$41.08M$0.0552.40 SummaryAdherex Technologies beats Cronos Group on 9 of the 17 factors compared between the two stocks. Get Adherex Technologies News Delivered to You Automatically Sign up to receive the latest news and ratings for FENC and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding FENC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FENC vs. The Competition Export to ExcelMetricAdherex TechnologiesMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$241.98M$3.13B$5.76B$10.41BDividend YieldN/A2.37%5.74%4.63%P/E Ratio-20.6420.5976.5226.72Price / Sales5.09385.20496.69161.98Price / Cash268.4645.3237.1760.63Price / Book-41.299.6513.716.39Net Income-$440K-$53.02M$3.29B$271.62M7 Day Performance-1.03%1.03%0.92%2.76%1 Month Performance9.61%7.85%6.19%9.54%1 Year Performance63.89%10.32%81.04%31.52% Adherex Technologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FENCAdherex Technologies2.2738 of 5 stars$8.67-2.9%$13.33+53.8%+71.1%$241.98M$47.54M-20.6410News CoverageHigh Trading VolumeCRONCronos Group2.2714 of 5 stars$2.55+0.8%N/A+17.6%$968.72M$117.61M51.00450CRMDCorMedix3.9742 of 5 stars$12.65-2.2%$18.00+42.3%+61.4%$965.96M$43.47M16.8730Insider TradeUPBUpstream Bio1.5848 of 5 stars$16.79-4.4%$56.50+236.5%N/A$947.19M$2.37M0.0038SYRESpyre Therapeutics2.6114 of 5 stars$14.84-5.2%$53.40+259.8%-47.1%$945.28M$890K-4.3673Analyst ForecastHigh Trading VolumeQUREuniQure2.764 of 5 stars$14.84-10.0%$37.45+152.4%+155.9%$904.48M$27.12M-3.79500News CoverageHigh Trading VolumeURGNUrogen Pharma4.0108 of 5 stars$18.06-3.9%$32.00+77.2%+44.0%$869.30M$90.40M-5.44200RAPPRapport Therapeutics3.1481 of 5 stars$24.73+4.1%$31.00+25.4%+31.2%$867.19MN/A-9.89N/AAnalyst ForecastABUSArbutus Biopharma2.3368 of 5 stars$4.53+1.6%$5.00+10.4%+7.0%$854.98M$15.42M-15.6290PHATPhathom Pharmaceuticals2.3996 of 5 stars$11.48-3.0%$17.50+52.4%-38.9%$839.97M$55.25M-2.43110TSHATaysha Gene Therapies2.4636 of 5 stars$3.02-1.6%$8.29+174.4%+39.1%$837.48M$8.33M-8.88180 Related Companies and Tools Related Companies Cronos Group Alternatives CorMedix Alternatives Upstream Bio Alternatives Spyre Therapeutics Alternatives uniQure Alternatives Urogen Pharma Alternatives Rapport Therapeutics Alternatives Arbutus Biopharma Alternatives Phathom Pharmaceuticals Alternatives Taysha Gene Therapies Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FENC) was last updated on 9/19/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredPrepare for the “Mar-a-Lago Accord” Money ShockWhy Are Wall Street Insiders Moving Their Money to This ONE Asset? Something far more consequential for you...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adherex Technologies Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Adherex Technologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free FENC Stock Alerts